Omniab Inc (OABI)

May 13, 2025, 4:05 PM EDT - 23 days ago

OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit

May 10, 2025, 3:52 AM EDT - 27 days ago

OmniAb, Inc. (OABI) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:06 PM EDT - 4 weeks ago

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

May 8, 2025, 4:05 PM EDT - 4 weeks ago

OmniAb Introduces the xPloration® Partner Access Program

May 5, 2025, 1:00 AM EDT - 4 weeks ago

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

May 1, 2025, 8:00 AM EDT - 5 weeks ago

OmniAb to Participate in Five Upcoming Investor Conferences

Apr 21, 2025, 8:00 AM EDT - 6 weeks ago

OmniAb Announces Two New Appointments to its Board of Directors

Mar 18, 2025, 7:37 PM EDT - 2 months ago

OmniAb, Inc. (OABI) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 4:05 PM EDT - 2 months ago

OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Feb 24, 2025, 8:00 AM EST - 3 months ago

OmniAb to Report Fourth Quarter 2024 Financial Results on March 18

Feb 3, 2025, 4:57 PM EST - 4 months ago

OmniAb to Participate in Two Investor Conferences in March

Jan 31, 2025, 11:09 AM EST - 4 months ago

Kuehn Law Encourages Investors of OmniAb, Inc. to Contact Law Firm

Dec 16, 2024, 4:15 PM EST - 6 months ago

OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference

Nov 12, 2024, 9:53 PM EST - 7 months ago

OmniAb, Inc. (OABI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:05 PM EST - 7 months ago

OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights

Oct 30, 2024, 8:00 AM EDT - 7 months ago

OmniAb to Participate in Two Investor Conferences in November

Oct 22, 2024, 8:00 AM EDT - 8 months ago

OmniAb to Report Third Quarter 2024 Financial Results on November 12

Aug 26, 2024, 8:00 AM EDT - 10 months ago

OmniAb to Participate in Two Investor Conferences in September

Aug 10, 2024, 11:28 AM EDT - 10 months ago

OmniAb, Inc. (OABI) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:05 PM EDT - 10 months ago

OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights

Aug 6, 2024, 8:25 AM EDT - 10 months ago

Long Assets On Path To Creating Significant Value, Shorting Remains Very Challenging

FIP FTAI IMVT PRPL REAL RICK

Jul 25, 2024, 8:00 AM EDT - 11 months ago

OmniAb to Report Second Quarter 2024 Financial Results on August 8

Jun 3, 2024, 4:05 PM EDT - 1 year ago

OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology

May 20, 2024, 8:05 AM EDT - 1 year ago

OmniAb to Participate in the Jefferies Global Healthcare Conference

May 15, 2024, 4:05 PM EDT - 1 year ago

OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit

May 10, 2024, 4:33 PM EDT - 1 year ago

OmniAb, Inc. (OABI) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:05 PM EDT - 1 year ago

OmniAb Reports First Quarter 2024 Financial Results and Business Highlights

May 1, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Participate in Five Investor Conferences in May

Apr 22, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Report First Quarter 2024 Financial Results on May 9

Apr 15, 2024, 8:31 AM EDT - 1 year ago

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate (ADC) Biotherapeutics

THAR

Mar 20, 2024, 7:38 PM EDT - 1 year ago

OmniAb, Inc. (OABI) Q4 2023 Earnings Call Transcript

Mar 20, 2024, 4:05 PM EDT - 1 year ago

OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Feb 26, 2024, 8:00 AM EST - 1 year ago

OmniAb to Report Fourth Quarter 2023 Financial Results on March 20

Dec 14, 2023, 4:30 PM EST - 1 year ago

OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference

Nov 14, 2023, 12:44 PM EST - 1 year ago

OmniAb, Inc. (OABI) Research and Technology Virtual Event and Q3 2023 Earnings Call Transcript

Nov 9, 2023, 5:55 PM EST - 1 year ago

OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today's Research & Technology Virtual Event

Nov 9, 2023, 8:00 AM EST - 1 year ago

OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights

Nov 1, 2023, 9:00 AM EDT - 1 year ago

OmniAb Appoints Steve Love to its Board of Directors

Oct 31, 2023, 4:28 PM EDT - 1 year ago

OmniAb Announces Agenda for its Research & Technology Virtual Event

Oct 12, 2023, 8:00 AM EDT - 1 year ago

OmniAb to Hold Research & Technology Virtual Event on November 9

Sep 25, 2023, 9:22 PM EDT - 1 year ago

OmniAb: Hold For Growth

Aug 12, 2023, 2:39 PM EDT - 1 year ago

OmniAb, Inc. (OABI) Q2 2023 Earnings Call Transcript

Aug 10, 2023, 4:05 PM EDT - 1 year ago

OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights

Aug 7, 2023, 4:05 PM EDT - 1 year ago

OmniAb Announces the Passing of Director Sunil Patel

Jul 31, 2023, 8:00 AM EDT - 2 years ago

OmniAb to Report Second Quarter 2023 Financial Results on August 10

Jun 29, 2023, 1:31 PM EDT - 2 years ago

OmniAb: Plenty Of Potential

May 17, 2023, 4:05 PM EDT - 2 years ago

OmniAb Launches OmniDeep™ at the PEGS Boston Conference and Expo

May 15, 2023, 11:27 AM EDT - 2 years ago

OmniAb: 6 Months In And Going Strong

May 12, 2023, 4:04 PM EDT - 2 years ago

OmniAb, Inc. (OABI) Q1 2023 Earnings Call Transcript

May 11, 2023, 7:00 AM EDT - 2 years ago

OmniAb Reports First Quarter 2023 Financial Results and Business Highlights